SciELO - Scientific Electronic Library Online

vol.116 issue3Pseudotumor cerebri associated with hypovitaminosis A, B6 and D: About two casesPleuropulmonary blastoma: case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Archivos argentinos de pediatría

Print version ISSN 0325-0075On-line version ISSN 1668-3501


ROSANOVA, María T et al. Use of posaconazole in children: Experience in a tertiary pediatric hospital. Arch. argent. pediatr. [online]. 2018, vol.116, n.3, pp.e451-e454. ISSN 0325-0075.

There is limited information on the use of posaconazole in children. This retrospective and descriptive study was conducted to evaluate the clinical, microbiological characteristics and evolution of patients treated with posaconazole between August 2010 and March 2017. We included 16 children. Median age: 161 months (interquartile range -IQR-69-173m). All had underlying disease and a proven invasive fungal infection. The most frequent isolated were Mucor spp. and Aspergillus spp. The mean posaconazole dose was 600 mg /day (400-800 mg/day) and the median duration of treatment was 223 days (IQR 48-632). Ten patients had adverse effects, but only one required suspension of the antifungal treatment due to hydroelectrolytic disorders.

Keywords : Posaconazole; Treatment; Invasivefungal infections; Child.

        · abstract in Spanish     · text in Spanish


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License